Skip to main content

International multidisciplinary expert panel reaches consensus for closed incision negative pressure therapy (ciNPT) with reticulated open cell foam (ROCF)

Solventum™ Prevena™ Therapy is the only ciNPT system with fully integrated linear and area dressings solely indicated for closed incisions that utilize ROCF technology

Secondary General Teaser Banner

Linear and Area Coverage with Closed Incision Negative Pressure Therapy Management: International Multidisciplinary Consensus Recommendations

D Singh, T Alton, A Alvand, PR Barbosa de Toledo, A Chatterjee, E Dillavou, R Djohan, AV Gomez Ortega, A Pieri, B Sumpio, C Willy, B Zelle, HJ Cooper

Abstract Summary

Closed incision negative pressure therapy (ciNPT) with foam dressings has evolved over time to include linear and area shapes to better conform to different incision types and surface geometries in support of incision healing. An international, multidisciplinary panel of experts convened to review recent publications on ciNPT with reticulated open cell foam (ROCF) dressings to provide guidance on dressing selection and explore the benefits, drawbacks and technical challenges. This manuscript establishes consensus statements regarding risk factors supporting the use of ciNPT, conditions supporting preference of linear or area ciNPT dressings and tips for practical application of ciNPT with ROCF dressings.

Key Messages

  • ciNPT can be applied using various sizes and shapes of foam dressing to support healing of a wide array of incision types and anatomical locations
  • To provide guidance on dressing selection and application, an international, multidisciplinary panel of experts reviewed recent studies on ciNPT with foam dressings, shared their experiences, and discussed the benefits, drawbacks, and technical challenges
  • The panel produced consensus statements regarding risk factors supporting the use of ciNPT, conditions supporting preference of linear or area ciNPT dressings and tips for practical application of ciNPT with foam dressings

Consensus Recommendations

An international multidisciplinary panel of experts reached consensus on the following for ciNPT with reticulated open cell foam (ROCF). These recommendations fell into three categories:

Solventum™ Prevena™ Therapy is the only ciNPT system with fully integrated linear and area dressings solely indicated for closed incisions that utilize ROCF technology.

Risk factors supporting the use of ciNPT dressings with ROCF

ciNPT is recommended:
  • when patient risk factors ≥ 2
  • when incision risk factors ≥ 2
  • for high-tension incision closures
  • for incisions with a high risk of seroma formation
  • for incisions after high-energy trauma
  • for incisions with a high risk of compromised perfusion
  • for repeated incisions or revision surgeries
  • for cases in which delayed incision healing would postpone adjuvant therapy
  • when there are signs of hypoperfusion near the incision
ciNPT:
  • may be offered for elective use for incisions in which scarring is a concern
  • when applied, should be used alongside validated incision risk scoring systems
  • should be included in surgical site infection (SSI) prevention bundles for high-risk patients

Watch the mechanism of action video to learn more about Prevena Therapy with ROCF dressing.

Interested in learning more about ciNPT with ROCF?

Connect with us to bring Prevena Therapy to your practice

We’re here to help! Our team of representatives can provide you with information and resources to help you. Submit the form below to speak with a Solventum representative to learn more about the consensus document and Prevena Therapy.

Fields marked with an * are required.

 

Solventum will use the information to respond to your request in accordance with our Privacy Policy